Larson Financial Group LLC Sorrento Therapeutics, Inc. Transaction History

Larson Financial Group LLC

  • $1.75 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$1.51 - $2.88 $7,550 - $14,400
5,000 Added 46.19%
15,825 $25,000
Q1 2022

May 05, 2022
BUY
$2.0 - $4.9 $12,080 - $29,596
6,040 Added 126.23%
10,825 $25,000
Q3 2021

Nov 04, 2021
BUY
$7.41 - $10.99 $6,654 - $9,869
898 Added 23.1%
4,785 $37,000
Q2 2021

Aug 10, 2021
BUY
$6.35 - $10.0 $24,682 - $38,870
3,887 New
3,887 $38,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email